BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22510351)

  • 21. Aberrant promoter methylation of hOGG1 may be associated with increased risk of non-small cell lung cancer.
    Qin H; Zhu J; Zeng Y; Du W; Shen D; Lei Z; Qian Q; Huang JA; Liu Z
    Oncotarget; 2017 Jan; 8(5):8330-8341. PubMed ID: 28039450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
    Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
    Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
    [No Abstract]   [Full Text] [Related]  

  • 23. HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients.
    Lissa D; Ishigame T; Noro R; Tucker MJ; Bliskovsky V; Shema S; Beck JA; Bowman ED; Harris CC; Robles AI
    Lung Cancer; 2018 Aug; 122():151-159. PubMed ID: 30032824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
    Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
    Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic determinants for promoter hypermethylation in the lungs of smokers: a candidate gene-based study.
    Leng S; Stidley CA; Liu Y; Edlund CK; Willink RP; Han Y; Landi MT; Thun M; Picchi MA; Bruse SE; Crowell RE; Van Den Berg D; Caporaso NE; Amos CI; Siegfried JM; Tesfaigzi Y; Gilliland FD; Belinsky SA
    Cancer Res; 2012 Feb; 72(3):707-15. PubMed ID: 22139380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project.
    Verri C; Roz L; Conte D; Liloglou T; Livio A; Vesin A; Fabbri A; Andriani F; Brambilla C; Tavecchio L; Calarco G; Calabrò E; Mancini A; Tosi D; Bossi P; Field JK; Brambilla E; Sozzi G;
    Am J Respir Crit Care Med; 2009 Mar; 179(5):396-401. PubMed ID: 19096006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TMEM196 hypermethylation as a novel diagnostic and prognostic biomarker for lung cancer.
    Liu WB; Han F; Huang YS; Chen HQ; Chen JP; Wang DD; Jiang X; Yin L; Cao J; Liu JY
    Mol Carcinog; 2019 Apr; 58(4):474-487. PubMed ID: 30536447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis.
    Liu F; Lu X; Zhou X; Huang H
    Thorac Cancer; 2021 Nov; 12(21):2907-2913. PubMed ID: 34545707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of two data mining models of lung cancer screening based on three gene promoter methylations combined with telomere damage.
    Wang W; Feng X; Duan X; Tan S; Wang S; Wang T; Feng F; Wu Y; Wu Y
    Int J Biol Markers; 2017 Mar; 32(1):e141-e146. PubMed ID: 27716889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation analysis in spontaneous sputum for lung cancer diagnosis.
    Hubers AJ; van der Drift MA; Prinsen CF; Witte BI; Wang Y; Shivapurkar N; Stastny V; Bolijn AS; Hol BE; Feng Z; Dekhuijzen PN; Gazdar AF; Thunnissen E
    Lung Cancer; 2014 May; 84(2):127-33. PubMed ID: 24598366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer.
    Nikolaidis G; Raji OY; Markopoulou S; Gosney JR; Bryan J; Warburton C; Walshaw M; Sheard J; Field JK; Liloglou T
    Cancer Res; 2012 Nov; 72(22):5692-701. PubMed ID: 22962272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
    Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
    PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchial biopsy specimen as a surrogate for DNA methylation analysis in inoperable lung cancer.
    Um SW; Kim HK; Kim Y; Lee BB; Kim D; Han J; Kim H; Shim YM; Kim DH
    Clin Epigenetics; 2017; 9():131. PubMed ID: 29270240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
    Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
    J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer.
    Diaz-Lagares A; Mendez-Gonzalez J; Hervas D; Saigi M; Pajares MJ; Garcia D; Crujerias AB; Pio R; Montuenga LM; Zulueta J; Nadal E; Rosell A; Esteller M; Sandoval J
    Clin Cancer Res; 2016 Jul; 22(13):3361-71. PubMed ID: 26842235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P16
    Tuo L; Sha S; Huayu Z; Du K
    Thorac Cancer; 2018 Aug; 9(8):1032-1040. PubMed ID: 29927090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung cancer risk stratification using methylation profile in the oral epithelium.
    Harada H; Miyamaoto K; Kimura M; Ishigami T; Taniyama K; Okada M
    Asian Cardiovasc Thorac Ann; 2019 Feb; 27(2):87-92. PubMed ID: 30417685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability in the measurement of the methylation status of lung cancer-related genes in bronchial secretions.
    Millares L; Rosell A; Setó L; Sanz J; Andreo F; Monsó E
    Oncol Rep; 2014 Oct; 32(4):1435-40. PubMed ID: 25069886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
    Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
    J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.